Skip to content

APOTHEEK SPYSSCHAERT

Active
Private limited companyfounded 1989active for 36 yearsDorpsplaats 20, 2390 Malle, BelgiumKBO/BCE: BE 0439.190.363
Summary

APOTHEEK SPYSSCHAERT has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €417,907 and a net result of €84,387. Equity is growing by about 6.1% per year across the filed financial years. Its solvency ranks better than 59% of 12,686 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
APOTHEEK SPYSSCHAERTActiveChecked score 95/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
≈ €1.2mturnover 2025, estimated
Staff
3 FTE
Equity
€417,907
Profit
€84,387
Turnover estimated from the gross margin
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Parent
GEERT SPYSSCHAERT · 99.87%
2025 accounts 59 days early3 of 7 deeds summarised
Why 95raises riskSector: Retail trade (NACE 47)lowers riskFounded in 1989Size: 3 FTE, total assets €930,468Liquidity: current ratio 2.56, cash €109,886, halvedShow the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 66% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 70+9
equity 44.9% of total assets
Liquidity 53-12
short-term debt 29.5% · cash 11.8%
Profitability 80+6
return on assets 9.1%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,259 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025lowest value 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026highest value 08-2026: 0.1%● unchanged vs 07-2026highest value 09-2026: 0.1%● unchanged vs 08-2026highest value 10-2026: 0.1%● unchanged vs 09-2026highest value
Credit of up to €35,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.56, compared with 1.91 in 2024, above the usual 1.5; short-term debt: 29.5% and cash: 11.8% of total assets), but 55.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 60% on solvency, 57% on liquidity, 71% on profitability and 77% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Founded in 1989
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Size: 3 FTE, total assets €930,468
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 2.56, cash €109,886, halved
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-06-2026, 59 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
59 days early
2024
14 days early
2023
22 days early
2022
28 days late
2021
59 days late
2020
73 days late
2019
39 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 15 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 July (4 of the last 5 filed years within 45 days of that day).
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Highest result from 2018 to 2025net €84,387 ▲123%
  3. Annual accounts filedfinancial year 2024 · abbreviated…

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €84,387 8 years View
  • Controlled by GEERT SPYSSCHAERT 99.87% View
  • Merger with GEERT SPYSSCHAERTmerger on 31-01-2025 2025 View
  • Positive: Equity rose in 2025from €333,520 to €417,907 ▲ 25.3% View

By topic

Financials

Financial year
2025
Total assets
€930,468
Profit
€84,387
Solvency
44.9%
Total assets▲ 0.8%
Net result
20182025
Go to Financials

Board & ownership

Board
2 members
Parent
GEERT SPYSSCHAERT · 99.87%
  • SPYSSCHAERT Geert Etienne SimonneDirector
  • SPYSSCHAERT Wim Joris KarelDirector
Go to Board & ownership

Timeline

Events
41
Since
1991
Next accounts
by 31-07-2027
  1. 31-01-2025Capital & shares · Purpose · Resignations…
  2. 22-11-2024Restructuring
  3. 09-07-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
08-12-1989
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
9
Who signs
Each director alone
Annual meeting
Last Friday of May at 19:00
Purpose
“De inrichting en uitbating van apotheken; De handel in,de fabricatie en bereiding van…” (deed in Dutch)
Go to Articles of association

Key facts about APOTHEEK SPYSSCHAERT

What is the company number of APOTHEEK SPYSSCHAERT?
0439.190.363. In Belgium the VAT number is the company number with BE in front: BE 0439.190.363.
Where is APOTHEEK SPYSSCHAERT based?
The registered office is at Dorpsplaats 20, 2390 Malle.Company details
What does APOTHEEK SPYSSCHAERT do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK SPYSSCHAERT?
Private limited company (BV).
When was APOTHEEK SPYSSCHAERT founded?
On 08-12-1989.
Is APOTHEEK SPYSSCHAERT still active?
Yes, APOTHEEK SPYSSCHAERT is an active enterprise in the KBO register.
How many employees does APOTHEEK SPYSSCHAERT have?
On average 3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK SPYSSCHAERT?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is APOTHEEK SPYSSCHAERT profitable?
In financial year 2025, APOTHEEK SPYSSCHAERT made a profit of €84,387.
Where can I find the annual accounts of APOTHEEK SPYSSCHAERT?
APOTHEEK SPYSSCHAERT filed 36 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK SPYSSCHAERT due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to APOTHEEK SPYSSCHAERT

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure